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1. Introduction 
Mesenchymal stem cells (MSCs) are progenitor cells that can be isolated from all connective 
tissues such as bone, adipose, cartilage, blood and muscle (Wang et al., 2009). MSCs have 
recently been described to localise within breast carcinomas where the stem cells integrate into 
tumour-associated stromal tissues whereby the MSCs promote breast cancer cell invasion and 
metastasis (Karnoub et al., 2007). Previous studies have demonstrated that when combine with 
weakly metastatic human breast carcinoma cells, bone marrow-derived mesenchymal stem 
cells (BMSCs) increase the metastatic potency of the cancer cells greatly (Hombauer & 
Minguell, 2000). This phenomenon was significantly observed in MCF-7 cells where increase 
in cancer cell proliferation was observed when the cancer cells were co-cultured on the BMSCs 
feeder layer. Furthermore, light and epifluorescence microscopy studies revealed that the 
MCF-7 cluster grew in a dispersed fashion on the BMSCs feeder layer due to the decrease 
expression of adhesive molecules, such as E-cadherin and epithelial-specific antigen (ESA), in 
the cancer cells. The interaction between the MCF-7 cells and the BMSCs likely causes the loss 
of the adhesive molecules in the cancer cells. A phenomenon similar to this interaction was 
also observed in our recent study. Indeed, the study found that the growth of the MCF-7 cells 
was enhanced not only when the cancer cells were adhesively co-cultured with the BMSCs but 
also when they were co-cultured non-adhesively.  
In the adhesive cell interaction, the growth or proliferation rate of the MCF-7 cells, which 
was measured by colony size, was observed to increase when the cancer cells were co-
cultured on the BMSCs feeder layer (Fig. 1A and Fig. 1B). The non-adhesive interaction of 
the MCF-7 cells with BMSCs was also found to increase the growth of the cancer cells. When 
the cancer cells were incubated with the conditioned medium (culture supernatant) of the 
BMSCs, the proliferation rate of the MCF-7 cells increased approximately 16.6% when 
compared to the proliferation rate of the cancer cells incubated with growth medium only 
(Fig. 1C). This phenomenon indicates that the increase in the proliferation rate of the cancer 
cells due to the presence of the BMSCs must not be related to a direct physical cell–cell 
interaction, as similar findings are observed in both the adhesive and non-adhesive co-
culture conditions. 
Note: In this chapter, adhesive co-culture is defined as the growth of cancer cells on a non-
tumorigenic cell monolayer where direct physical cell–cell interaction occurs. Non-adhesive 
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co-culture is defined as the incubation of cancer cells with a conditioned medium that is 
withdrawn from the non-tumorigenic cells; here, the cells interact with one another via the 
culture medium. 
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Fig. 1. Colony formation of the MCF-7 cells cultured with or without BMSCs. The pictures 
show Oil-Red-O staining of (A) the MCF-7 colonies alone and (B) the MCF-7 colonies grown 
on the BMSCs feeder layer for one week. The pictures were visualised under an inverted 
light microscope using same magnification. (C) The proliferation rate of the MCF-7 cells 
incubated with cell growth medium (control) and conditioned medium of BMSCs for one 
week. One hundred cells were used as the input prior to incubation. The values were 
expressed as mean±SD from three replicates, and the determination was carried out from 
three replicates each of three independent experiments.  
The BMSCs likely secreted or influenced the MCF-7 cells to secrete certain soluble growth 
factors into the conditioned medium whereby the growth factors stimulated the MCF-7 cells 
in cluster and grow into single cell layer, after which the cells dispersed without any 
(A) (B) 
(C) 
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evidence of direct cell–cell contact (Fig. 2). Thus, the influence of the BMSCs on the changed 
of cell morphology and increased proliferation rate of the MCF-7 cells may be achieved via 
the culture medium without the need for any direct physical cell–cell interaction between 
the two cell lines. However, this phenomenon, in which the BMSCs increased the 
proliferation rate of the breast cancer cells, was not observed when the BMSCs were co-
cultured with highly invasive and metastatic human breast cancer cells, such as MDA-MB-
231 cells. The MDA-MB-231 cell line likely contains its own source that similar to the MSCs 
as progenitor factor in the cell population that is able to secrete a standard level of the 
soluble growth factors into the conditioned medium of the MDA-MB-231 cells. Therefore, 
the activity of the MDA-MB-231 cells was not influenced by their exposure to the MSCs-
conditioned medium and few effects were observed when the cells were co-cultured with 
the MSCs (Sasser et al., 2007a). 
 
   
   
Fig. 2. Unstained MCF-7 and MDA-MB-231 cells as visualised under an inverted light 
microscope. Panels A and B show clustered and single cell layer of MCF-7 cells that were 
incubated with cell growth medium and BMSCs-conditioned medium, respectively, 
whereas panels C and D show few effects on cell morphology were observed when the 
MDA-MB-231 cells were incubated with cell growth medium and BMSCs-conditioned 
medium, respectively. The pictures were taken after one week of cell incubations.  
(A) (B) 
(C) (D) 
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2. Soluble growth factors in the conditioned medium of the MDA-MB-231 
cells 
2.1 Expression of MMPs in the conditioned medium 
The MDA-MB-231 cell line is an estrogen receptor alpha (ER)-negative human breast 
cancer cell line (Liu et al., 2003). It was derived from a metastatic adenocarcinoma of the 
mammary gland of a 51-year-old Caucasian woman, according to the data sheet of the 
American Type Culture Collection (ATCC). This adherent epithelial cell line that likely 
contains more than one cell populations is a highly aggressive, invasive and poorly-
differentiated human breast cancer cell line. Similar to other invasive cancer cell lines, the 
MDA-MB-231 cells display the invasiveness by mediating the proteolytic degradation of the 
extracellular matrix (ECM), including basement membrane and several mechanical barriers 
to the ECM, through the increased expression of matrix metalloproteinases (MMPs), 
including gelatinases, en route to their destinations (Fig. 3).  
 
 
Fig. 3. Illustration depicts the ECM in relationship to the epithelium, endothelium and 
connective tissues. To reach their destination, the invasive cancer cells must penetrate the 
mechanical barriers of the ECM and basement membrane through proteolytic degradation. 
The figure was modified from the Wikimedia. 
Type IV collagen, which is the main component of the basement membrane, is the first 
component that must be degraded to allow the invasion process (Boutaud et al., 2000). The 
ability to degrade and penetrate the basement membrane is related with an increased 
potential of the cells for invasion and metastasis (Castro-Sanchez et al., 2011). Tumour cells 
are able to produce MMPs that degrade the matrix barriers surrounding the tumour, 
including basement membrane, permitting invasion into connective tissues, entry and exit 
from blood and lymphatic vessels, and metastasis to distant organs. MMPs are family of 
zinc-dependent endopeptidases that collectively are capable of degrading all components of 
the ECM, including the basement membrane. Binding of breast cancer cells to type IV 
collagen in the basement membrane induces Discoidin domain receptor 1 (DDR1) activation 
and then it triggers signal transduction pathways and cellular processes that promotes 
secretion of MMPs which contributes to basement membrane degradation and cancer cell 
Epithelial cells 
Basement  
membrane 
Endothelium lining  
the capillary 
Connective tissues 
Fibroblast 
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invasion. A previous study demonstrated that gelatinase B or MMP-9, which degrades the 
type IV collagen in the basement membrane, plays a crucial role in the invasion process of 
the MDA-MB-231 cells (Liu et al., 2003). This phenomenon can be observed by determining 
the metastatic potential of the MDA-MB-231 cells in an experimental model that is closely 
correlated with the expression of the MMP-9 and the activities of the gelatinases in the 
conditioned medium of the MDA-MB-231 cells. According to the study, the invasion of the 
MDA-MB-231 cells was blocked by MMP-9-neutralising antibodies that reduced the 
gelatinolytic activities in the conditioned medium, as detected using Enzyme-linked 
immunosorbent assay (ELISA). This phenomenon also led to the significant inhibition of the 
invasive capacities of the MDA-MB-231 cells. This inhibition was induced by specific drugs 
e.g., peroxisome proliferator-activated receptor gamma ligands and all-trans-retinoic acid 
that were administered on a reconstituted basement membrane in a Matrigel® chamber in 
vitro. Therefore, MMP-9 was shown to play a crucial role in the invasion process of the 
MDA-MB-231 cells and it was shown to be absolutely required for the transmigration of this 
cell line. 
Note: In this chapter, conditioned medium is denoted as culture supernatant that is 
withdrawn from feeder layer. To accomplish this, a culture of feeder layer e.g., BMSCs is 
maintained with fresh growth medium. After certain duration, the growth medium is 
withdrawn from the feeder layer as conditioned medium. The conditioned medium is 
believed to contain growth factors released by the feeder layer. 
2.2 Activation of STAT3 and soluble IL-6 in the conditioned medium 
In addition to MMP-9 in the conditioned medium, the MDA-MB-231 cells are also 
demonstrated to contain elevated level of signal transducer and activator of transcription 3 
(STAT3) in the cells (Sasser et al., 2007b). STAT3 is typically maintained in the cytoplasm as 
an inactive monomer. Once it is phosphorylated, the STAT3 forms homodimers and enters 
into nucleus where it activates the transcription of multiple genes associated with cell 
proliferation and survival (Heinrich et al., 1998; Zinzalla et al., 2010). The activation of STAT3 
has been correlated with enhanced breast cancer cell growth, survival and immune evasion 
(Selander et al., 2004; Ling et al., 2005; Yu et al., 2007). According to a previous study, 
exposure of MSCs-conditioned medium to MCF-7 and T-47D activated the levels of pTyr705 
STAT3 in the cells (Sasser et al., 2007a). Correlatively, the enhancement of the cancer cell 
growth rates was observed in ER-positive human breast cancer cell lines, including MCF-7 
and T-47D, in the presence of the MSCs-conditioned medium. The growth rates of BT474 
and ZR-75-1 cells were also observed to increase after the cancer cells were co-cultured with 
the MSCs-conditioned medium. All cancer cell growth rates were enhanced by 
approximately 2-3 fold, after the exposure to the conditioned medium (Fig. 4). The growth 
rate of an ER-negative breast cancer cell line, MDA-MB-468, was also elevated in the 
presence of the MSCs-conditioned medium, albeit to a lesser extent than the other ER-
positive cell lines that were tested (Sasser et al., 2007a; Sasser et al., 2007b). However, this 
induction was not observed when the MDA-MB-231 cell line was exposed to the MSCs-
conditioned medium.  
Few effects were observed when the MDA-MB-231 cells were co-cultured with the MSCs-
conditioned medium because the cell line likely contained a subpopulation in the cell 
population that secreted a standard level of soluble growth factors in the conditioned 
medium (Sasser et al., 2007b). In this non-adhesive co-culture study, paracrine interleukin-6 
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Fig. 4. Breast cancer cell growth in the presence or absence of MSCs-conditioned medium 
was assessed for MDA-MB-231, MCF-7, BT474, T47D and ZR-75-1 cells. The MDA-MB-231 
cell growth was unaltered by MSCs-conditioned medium, whereas the growth of the four 
remaining ER-positive cell lines in the presence of MSCs-conditioned medium was 
significantly elevated when compared to the cell lines growing alone for eight days (Sasser 
et al., 2007b). 
(IL-6) was found to be the principal mediator of the STAT3 phosphorylation in the cells. 
MSCs-induced STAT3 phosphorylation was lost when the IL-6 was depleted from the 
MSCs-conditioned medium. A similar phenomenon was observed when the IL-6 receptor in 
the cancer cells was blocked. This secretion of IL-6 from the MDA-MB-231 cells allowed for 
the activation and maintenance of the level of STAT3 as well as the growth in the MDA-MB-
231 cells. Therefore, the conditioned medium of MDA-MB-231 cells has similar effect as the 
conditioned medium withdrawal from the MSCs, as evidenced by previous study, where 
the conditioned medium from the MDA-MB-231 cells with constitutively active STAT3 is 
sufficient to induce p-STAT3 levels in various recipients that do not possess elevated p-
STAT3 levels, such as MCF-10A cells, a non-tumorigenic cell line (Lieblein et al., 2008). This 
signalling occurs through the JAK/STAT3 pathway, leading to STAT3 phosphorylation as 
early as 30 minutes and was persistent for at least 24 hours, indicating that a correlation 
between elevated levels of IL-6 production and p-STAT3 in the cells, as confirmed by ELISA 
analysis. Neutralisation of the IL-6 ligand or gp130 was sufficient to block the increased 
levels of p-STAT3 (Y705) in the treated cells. These results demonstrate that the STAT3 
phosphorylation in breast epithelial cells can be stimulated by paracrine signalling through 
soluble growth factors from both breast cancer cells and breast cancer associated fibroblasts 
with elevated STAT3 phosphorylation. The finding of growth factors within the MDA-MB-
231 conditioned media was also sufficient to stimulate an increase in IL-6 production from 
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MCF-10A cells, as indicated in the previous study, may not correct as both MDA-MB-231 
cells and MCF-10A cells secret IL-6 in the conditioned medium. Indeed, our study 
demonstrated that the conditioned media of the MDA-MB-231 cells and MCF-10A cells 
contained a high level of IL-6, although the level was not as high as in the MSCs-conditioned 
medium (Fig. 5).  
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Fig. 5. The activity of IL-6 in the conditioned media of MSCs, non-tumorigenic cells and 
human breast cancer cells. The culture supernatants were withdrawn from one-week-old 
feeder layer of above cultures. The level of IL-6 in the conditioned medium was assayed 
using ELISA. The values were expressed as the mean±SD from three replicates, and the 
determination was carried out from three replicates each of three independent experiments.  
Therefore, the finding indicates that the soluble growth factors within the MDA-MB-231 
conditioned medium to stimulate an increase in IL-6 production from the MCF-10A cells 
might be due to combine of both conditioned media. Anyhow, this result indicates that the 
MDA-MB-231 cells may contain similar progenitor factor as MSCs in the cell population. 
This factor likely expresses the high level of IL-6 where it contributes to the induction of 
STAT3 phosphorylation and appears to be associated with cell proliferation of the MDA-
MB-231 cells. Although the secretion of IL-6 allows for the activation and maintenance of the 
level of STAT3 as well as the growth in the MDA-MB-231 cells have been demonstrated, its 
role in invasiveness of the MDA-MB-231 remains unclear. Nevertheless, targeting the IL-6 in 
the conditioned medium can be an idea to diagnose patients with tumour that are ER 
negative or express lower level of ER. 
2.3 CCL2 and CCL5 in the conditioned medium 
Chemokines or chemotactic cytokines are small proteins that are classified into four 
conserved groups, CXC, CC, C and CX3C, based on the position of the first two cysteines 
that are adjacent to the amino acid (Balkwill, 2004; Lu & Kang, 2009). Among more than 50 
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identified human chemokines, chemokine (C-C motif) ligand 2 (CCL2 or MCP-1) and 
chemokine (C-C motif) ligand 5 (CCL5 or RANTES) are of particularly important. CCL2 is a 
potent chemoattractant for monocytes, memory T lymphocytes and natural killer cells whereas 
CCL5 is a potent inducer of leukocyte motility (Lu & Kang, 2009; Melgarejo et al., 2009; Yaal-
Hahoshen et al., 2006). Both chemokines stimulate migration of leukocytes in response to 
inflammatory signals. The roles of CCL2 and CCL5 in breast malignancy have been 
extensively addressed in breast cancer studies (Goldberg-Bittman et al., 2004; Soria et al., 2008; 
Soria & Ben-Baruch, 2008; Wu et al., 2008; Fujimoto et al., 2009). Overexpression of the CCL2 
and CCL5 are stimulated during breast cancer development and progression. They are also 
frequently associated with advanced tumour stage and metastatic relapse in breast cancer. 
Both chemokines act directly on the tumour cells to promote their pro-malignancy phenotype 
by increasing their migratory and invasion-related properties (Soria & Ben-Baruch, 2008). The 
chemokines are expressed by the cells of the tumour microenvironment osteoblasts and MSCs. 
In breast cells, the chemokines are highly expressed by breast tumour cells at primary tumour 
sites and minimally expressed by normal breast epithelial duct cells (Soria et al., 2008; Soria & 
Ben-Baruch, 2008). The chemokines are soluble growth factors that can be easily detected in 
serum and conditioned culture medium. Consistently, our recent study demonstrated that 
high levels of CCL2 and CCL5 were detected in the conditioned medium of the MDA-MB-231 
cells, as determined by ELISA (Fig. 6). The results indicated that the CCL2 and CCL5 were 
present in the conditioned media of all of the tested cell lines. As expected, elevated levels of 
CCL2 and CCL5 were observed in the MSCs and MCF-10A cells. CCL2 was additionally more 
stably expressed in the non-tumorigenic cells, such as MCF-10A, than in the MDA-MB-231 
cells. However, an opposite event was observed for CCL5 in the MCF-10A and MDA-MB-231 
cells. Both CCL2 and CCL5 displayed relatively higher expression levels in the MDA-MB-231 
cells than that in the weakly metastatic cells, such as MCF-7 and BT-474. However, the CCL2 
level in the MDA-MB-231 cells was only slightly higher than in the MCF-7 and BT-474 cells.  
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Fig. 6. The activities of (A) CCL2 and (B) CCL5 in the conditioned media of MSCs, human 
breast tumorigenic and non-tumorigenic cells. The levels of the soluble growth factors were 
assayed using ELISA. The values were expressed as mean±SD from three replicates, and the 
determination was carried out from three replicates each of three independent experiments. 
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The overexpression of chemokine decoy receptor proteins, such as D6 and Duffy antigen 
receptor for chemokines (DARC), have been demonstrated to inhibit the proliferation and 
invasion of the human breast cancer in vitro, tumorigenesis and lung metastasis in vivo (Wu 
et al., 2008). This inhibition is associated with decrease in chemokines, such as CCL2 and 
CCL5, vessel density and tumour-associated macrophage infiltration. The inhibition of 
CCL5 expression by short interfering RNA (siRNA) or by the use of neutralising antibodies 
against CCL5 impaired the tumour-supporting roles that were mediated by the CCL5-CCR5 
loop; this significantly inhibited the metastatic potential of the MDA-MB-231 cells (Karnoub 
et al., 2007; Soria & Ben-Baruch, 2008). Moreover, CCL2-neutralizing antibodies inhibited 
bone resorption in vitro and bone metastasis in vivo as well as the tumour conditioned 
media-induced osteoclast formation in vitro and bone metastasis in vivo, indicating a role of 
the CCL2 and CCL5 in metastasis (Lu & Kang, 2009). The MDA-MB-231 cells are obviously 
having its own progenitor factor, which is in the cell population that produce the soluble 
growth factors in order to maintain the invasive and progressive phenotypes in the cells. 
Further identification and functional characterisation of CCL2 and CCL5, as well as MMP-9 
and IL-6, would provide an effective treatment for systemic metastasis. Perhaps, the effects 
of certain inhibitors or drugs on the inhibition of proliferation and the reduction of invasion 
of breast cancer cell growth can be easily determined using these growth factors as they can 
be detected via serum and conditioned culture medium. Thus, all four molecules mentioned 
in this chapter could be considered as potential therapeutic targets for the development of a 
detection assay for human breast cancer.  
3. The subpopulation in the MDA-MB-231 cells 
Most of the cancer cell lines have recently been demonstrated by flow cytometry to 
contain a subpopulation of CD44+/CD24- where the MDA-MB-231 cells are found to 
contain a high percentage of the CD44+/CD24- subpopulation (85±5%) in the cells 
(Sheridan et al., 2006). Other cell lines that contain a high level of this subpopulation are 
MDA-MB-436 (72±5%), Hs578T (86±5%) and SUM1315 (97±3%) (Table 1). The 
subpopulation is shown to possess the capacity for self-renewal and the generation of 
heterogeneous progeny in the cells. Moreover, the subpopulation of the breast cancer cells 
has been reported to have stem/progenitor cell properties that contribute a unique ability 
to allow these cells to invade. Similar to the ability of the MSCs that was described above, 
the inherent properties of this subpopulation may impart their transformed counterparts 
with the ability to evade traditional antitumour therapies and to establish breast cancer 
metastasis (Reya et al., 2001; Behbod et al., 2005; Dean et al., 2005). Several studies 
suggested that this subpopulation of cells, as a subset of human breast cancer cells, 
possessed an enhanced ability to form tumour in immunocompromised mice (Al-Hajj et 
al., 2003; Ponti et al., 2005). However, the potential of this subpopulation to establish 
breast cancer metastasis in the cell line remains unclear. 
The expression levels of pro-invasive genes, such as interleukin-1-alpha (IL-1), IL-6, 
interleukin-8 (IL-8) and urokinase plasminogen activator (UPA), are higher in the cell lines 
that contained a significant CD44+/CD24- subpopulation (Sheridan et al., 2006). The results 
indicate that the cell lines with a significant number of CD44+/CD24- subpopulation are more 
invasive is consistent with the studies that demonstrate the metastatic process in breast cancer 
cells requires the following: (1) ECM degradation-associated proteins, including the 
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UPA/UPA receptor system and MMPs; (2) cytokines, including interleukin-1 (IL-1), IL-6, IL-8, 
interleukin-11 (IL-11), tumour necrosis factor (TNF) and transforming growth factor-beta 1 
(TGF-1); and (3) chemokines and their receptors, including stromal cell-derived factor-1-
alpha (SDF-1) and CXC chemokine receptor (CXCR4) (Edwards and Murphy, 1998; Dumont 
and Arteaga, 2003; Kang et al., 2003; Yodkeeree et al., 2010). In addition, a recent study 
described the role of nuclear factor-kappa B (NF-B) and its ligand in the metastasis of breast 
cancer cells to the bone matrix (Jones et al., 2006). All of these factors may be directly related to 
breast cancer metastasis. However, the contribution of the subpopulation of CD44+/CD24- to 
the pro-invasive factors in breast cancer cells remains unclear. 
 
No. Cell Line CD44+/CD24- Cell Type Classification 
a MDA-MB-231 85±5 Mesenchymal 
b MDA-MB-436 72±5 Myoepithelial 
c Hs578T 86±5 Mesenchymal 
d MDA-MB-468 3±1 Basal 
e MCF-7 0 Luminal 
f T47-D 0 Luminal 
g ZR-75-1 0 Luminal 
h BT-474 0 Luminal/ErbB2+ 
i SK-BR-3 0 Luminal/ErbB2+ 
j MCF-10A 17±4 Basal 
Table 1. Subpopulation of CD44+/CD24- in commonly used breast cancer cell lines. The 
CD44 and CD24 expression patterns in the subpopulation CD44+/CD24- were determined 
by flow cytometry. CD44 and CD24 were detected by a combination of fluorochrome-
conjugated monoclonal antibodies against human CD44 (FITC) and CD24 (PE), respectively 
(Sheridan et al., 2006). 
Demethoxycurcumin (DMC) is recently demonstrated to inhibit the adhesion, migration and 
invasion of the MDA-MB-231 cells (Yodkeeree et al., 2010). According to the study, the 
DMC-treated MDA-MB-231 cells contained decreasing levels of ECM degradation-
associated proteins, which included MMP-9, membrane type-1 MMP (MT1-MMP), UPA and 
UPAR. DMC reduced also the expression of intercellular adhesion molecule-1 (ICAM-1) and 
CXCR4 in the MDA-MB-231 cells. These molecules are involved in the modulation of the 
tumour metastasis process. In addition, the study showed that treatment of the MDA-MB-
231 cells with DMC inhibited the DNA binding activity of NF-B, which is known to 
mediate the expression of MMPs, UPA, UPAR, ICAM-1 and CXCR4 in breast cancer cells. 
These results indicated also that NF-B may play a role in the invasion process of the MDA-
MB-231 cells. All of these findings suggest the presence of a correlation between the above 
molecules and the invasiveness of the MDA-MB-231 cells. However, the specific correlation 
between the above molecules and the subpopulation in the MDA-MB-231 cells has yet to be 
fully elucidated. The inhibition or depletion of the progenitor factor from the subpopulation 
is hypothesised to reduce the expression of the above molecules, thereby reducing the 
invasiveness of the MDA-MB-231 cells. Therefore, it is essential to identify more surface 
markers that can specifically be used to isolate the subpopulation. By targeting this 
subpopulation in the cells, the expression of the above molecules and the invasiveness of the 
MDA-MB-231 cells can be further elucidated. 
www.intechopen.com
 The Mesenchymal-Like Phenotype of the MDA-MB-231 Cell Line 
 
395 
4. Mesenchymal-like phenotype of the MDA-MB-231 cells 
Before the subpopulation and invasiveness of the MDA-MB-231 cells can be further elucidated, 
hierarchy of the breast cancer stem cells in the breast cancer cell compartment should be 
understood. A breast cancer stem cell, as described in the cancer stem cell compartment 
hierarchy, is capable of undergoing an asymmetric cell division to generate one cell that is 
identical to itself (orange colour) and one that it is more committed towards a certain 
differentiation pattern (a breast cancer cell, grey colour) (Cariati & Purushotham, 2008; Fig. 7). 
 
 
 
 
 
  
 
 
Fig. 7. A breast cancer stem cells-breast cancer cells compartment hierarchy. A breast cancer 
stem cell is capable of going through an asymmetric cell division to generate one cell that is 
identical to itself (orange colour) and one that tends toward a certain differentiation pattern 
(breast cancer cells, grey colour) (Modified from Cariati & Rurushotham, 2008). 
The formation of the identical cell ensures that the cancer stem cell compartment is 
maintained throughout its time in the subpopulation. These distinct cells undergo series of 
divisions and differentiation steps that result in the generation of a terminally differentiated 
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population of breast cancer stem cells and breast cancer cells. The existence of these cancer 
stem cells explains why only a small minority of cancer cells are capable of extensive 
proliferate and transfer to the tumour. Chemotherapy can remove breast cancer cells, but it 
fails to eliminate the cancer stem cells that can revive the breast cancer cells. This allows the 
regrowth of the breast cancer after the treatment has ended (Sanchez-Garcia et al., 2008). 
This shortcoming explains the high recurrence of the disease. Therefore, the current strategy 
for the development of anti-breast cancer agents is to target both breast cancer stem cells 
and breast cancer cells. Moreover, the healthy breast cells transform into cancer cells via the 
formation of breast cancer stem cells is also a possibility, but, the precise mechanism of the 
transformation for this disease remains unclear. Therefore, study of the transformation 
remains warranted. By understanding the precise mechanism that transforms normal stem 
cells into cancer cells via the formation of the cancer stem cells, it would be possible to 
develop more effective tools for the ER-negative human breast cancer prevention, 
detection and treatment. 
The MDA-MB-231 cell line is a good example of a breast cancer cell line that consists of 
the above mentioned populations of breast cancer stem cells and breast cancer cells. As 
described above, the MDA-MB-231 cells have been demonstrated to contain a 
subpopulation of CD44+/CD24- that provides stem/progenitor cell properties to enhance 
the invasiveness of the cancer cells. Surprisingly, in our present study, we found that the 
MDA-MB-231 cells were positive for CD105 staining, while the weakly metastatic breast 
cancer cell lines, such as MCF-7 and T47D, were negative for the CD105 staining; the 
staining was visualised by fluorescent microscopy (Fig. 8A). CD105, also known as 
Endoglin, is a type I integral trans-membrane glycoprotein and is an accessory receptor 
for transforming growth factor-alpha (TGF) superfamily ligands (Barbara et al., 1999). 
CD105 is found on activated monocytes, mesenchymal stromal cells and leukemic cells of 
lymphoid and myeloid lineages. The BMSCs, as well as other non-hematopoietic MSCs, 
are positive for the CD105 antibody staining, as visualised by fluorescent microscopy 
(Miao et al., 2006; Bernacki et al., 2008). Therefore, it is hypothesised that the MDA-MB-231 
cells may have similar mesenchymal phenotypes as the progenitor factors that contribute 
to the metastatic potency of the cancer cells. Therefore, the cell line contains not only the 
stem/progenitor cell properties but also the mesenchymal-like stem/progenitor cell 
properties. This property likely contributes to the invasiveness of the cell line and causes 
the cell line to express high levels of MMP-9, IL-6, CCL2 and CCL5 in the conditioned 
medium. The Oil-Red-O-stained MDA-MB-231 cells were also observed to contain a 
mixture of epithelial cells and a mesenchymal-like subpopulation, as visualised by light 
microscopy (Fig. 8B). 
These results focused our attention and research on the mesenchymal-like phenotype in 
the MDA-MB-231 cells. MDA-MB-231 and MCF-7 are cell lines that originate from pleural 
effusion metastatic cells in ductal invasive breast carcinomas (Burdall et al., 2003; Lacroix 
& Leclercq, 2004). These cells are among the most commonly used breast cancer cell lines 
in medical research laboratories. MDA-MB-231 is a mesenchymal-like cell line that is 
highly aggressive and invasive, whereas MCF-7 is classified as a luminal (epithelial)-like 
cell line with a relatively low invasive phenotype and potential (Lacroix & Leclercq, 2004; 
Charafe-Jauffret et al., 2006). A comparison of the two cell lines in terms of DNA copy 
number variation and gene expression profiles has been performed, and the expression 
levels of 2157 transcripts were shown to be significantly increased in the MDAMB-231 
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cells compared with the MCF-7 cells; the expression levels of 2345 transcripts were 
significantly increased in the MCF-7 cells compared with the MDA-MB-231 cells (Forozon 
et al., 2000; Charafe-Jauffret et al., 2006). Moreover, 387 of the above transcripts have been 
defined by the gene expression profile to be mesenchymal-like cellular subtypes (Charafe-
Jauffret et al., 2006). Recently, 31 mesenchymal-like and luminal-like subtype features of 
breast cancer cell lines were revealed in Charafe-Jauffret’s study, which was based on the 
gene expression profiles. The study found that 680 transcripts were preferentially 
expressed in the group of mesenchymal-like cell lines, and 629 transcripts were expressed 
preferentially in the group of luminal-like breast cancer cell lines. In a recent expression 
study, 387 transcripts, which are also identified in the mesenchymal-like subtype gene list 
in Charafe-Jauffret's study, showed significantly higher expression levels in the MDA-
MB-231 cells; and 328 transcripts, which were present on the luminal subtype gene list 
from Charafe-Jauffret's study, showed significantly higher expression levels in the MCF-7 
cells (Li et al., 2009). These data revealed the differential expression profiles of 
mesenchymal-like and luminal-like subtypes of the breast cancer cell lines. These 
expression profiles can be utilised to effectively overcome the invasion and metastasis of 
human breast cancer. 
 
 
 
      
 
Fig. 8. A: The MDA-MB-231 cells, which were predicted to have a mesenchymal-like 
phenotype subpopulation, existed in the epithelial cell population. The cells were stained 
with Oil-red O and visualised using an inverted light microscope. B: The MDA-MB-231 cells 
were positive for the CD105 antibody staining as visualised using fluorescent microscope. 
These images were captured using a digital camera. 
5. Future prospects 
Our recent study proposes to isolate or withdraw the mesenchymal-like stem cells from 
the MDA-MB-231 population using CD105 and other known antibody-conjugated 
microbeads, thus allowing for a clearer understanding of the subpopulation of the cancer 
cells. Potential drugs will then be applied to the isolated CD105+ (mesenchymal-like stem 
(A) (B) 
Mesenchymal-like cells 
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cells) and CD105- (epithelial cells) MDA-MB-231 cells. The invasion rate of the drug-
treated CD105+ and CD105- MDA-MB-231 will then be determined using the Matrigel 
invasion assay. The mRNA and protein expression levels of the ECM degradation-
associated molecules in the drug-treated CD105+ and CD105- MDA-MB-231 cells will also 
be assessed using real-time PCR and Western Blotting, respectively, and the gelatinase 
activities in the conditioned medium of drug-treated CD105+ and CD105- MDA-MB-231 
cells will be investigated using ELISA. The proposed project that will utilise cell 
separation and isolation techniques to study the breast cancer cell invasion is a new area 
of cancer research in the institute of my home country. The previous research projects 
regarding the MDA-MB-231 cell invasion and metastasis were related to drug treatments, 
the effects of herbal and plant extracts, and the understanding of a gene or protein activity 
in cancer cells and animal models. However, the approaches to study the cancer cell 
invasion and metastasis by isolating or withdrawing the mesenchymal-like breast cancer 
cells (CD105+) from the MDA-MB-231 cell population using cell separation or isolation 
have not been demonstrated. Therefore, this project may establish a new fundamental 
cancer research and new research topic in my institute. This study may also lay a research 
foundation that is focused on the inhibition of invasion for the ER-negative human 
breast cancer cells. I also believe that, by targeting the mesenchymal-like phenotype in the 
MDA-MB-231 subpopulation, the invasion rate of the ER-negative human breast cancer 
cells can be easily monitored and controlled.  
6. Conclusion 
All of the results mentioned above show that the MDA-MB-231 cells likely display a 
mesenchymal-like phenotype that facilitates the cells to be a highly metastatic breast cancer 
cell line. However, a deeper understanding of the cell morphology, gene expression and 
intracellular mechanisms and pathways of the cancer cells that can explain the interaction 
between mesenchymal-like and epithelial cells in the MDA-MB-231 cells is warranted. By 
targeting this phenotype, the metastatic potency and the growth of the cancer cells may be 
controlled or effectively reduced. A potential anticancer drug can also be identified to treat 
both human breast cancers and other malignancies. Perhaps, withdrawing the progenitor 
factor from a tumour may serve as a potential machinery target in cell-mediated therapy for 
human breast cancer. 
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